Copd News Archives

Formoterol is increasingly viewed as the long-acting I22-agonist of choice by pharmaceutical companies wishing to participate in the dynamic inhaled corticosteroid plus long-acting I22-agonist combination therapy segment of the asthma and chronic obstructive pulmonary disease market.

QVA149 is a novel once-daily, dry powder fixed dose bronchodilator combination of the once-daily beta2agonist QAB149 and the LAMA, NVA237 , for the treatment of chronic obstructive pulmonary disease .

Swiss drugmaker Novartis said a respiratory medicine improved lung function and significantly reduced breathlessness in a late stage trial.

Are you an asthma sufferer? Manage your asthma or COPD with great ideas from people like you.

COPD is an under-diagnosed progressive lung disease that may lead to death. In Canada, approximately 500,000 people over the age of 35 have been diagnosed with COPD, and it is estimated that an almost equal number of middle-aged Canadians may also have COPD, but are not aware of it.i In fact, by 2020, it is estimated that COPD will be the third ...

Nycomed A/Sa s Daxas pill improves lung function and reduces flareups in patients suffering from smokera s cough, according to two articles in The Lancet .

In patients with moderate chronic obstructive pulmonary disease , treatment with tiotropium may reduce the rate of decline in lung function and increase the time to exacerbations, suggesting that treatment should begin at an early stage of the disease, according to a study published online Aug.